Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München

  • WKN: 843002
  • ISIN: DE0008430026
  • Land: Germany

Nachricht vom 19.10.2021 | 13:43

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Despite high losses, Munich Re achieves a result of around €0.4bn in Q3, and maintains its annual guidance for 2021

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München / Key word(s): Quarter Results
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München: Despite high losses, Munich Re achieves a result of around €0.4bn in Q3, and maintains its annual guidance for 2021

19-Oct-2021 / 13:43 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


In Q3 2021, Munich Re's result was burdened by high losses from natural catastrophes. The company estimates that windstorm Bernd, which led to flooding and flash floods in Germany and neighbouring countries, will cost roughly €0.6bn in the segments property-casualty reinsurance and ERGO Property-casualty Germany. And in the USA, Hurricane Ida caused losses totalling roughly €1.2bn in property-casualty reinsurance.

Thanks to continued positive performance in all segments and a high investment result - also due in part to large gains on disposals - as well as a high currency translation result, Munich Re nevertheless achieved a preliminary result of around €0.4bn in Q3 (consensus: -€10m*).

Munich Re thus attained a result of roughly €2.1bn for the first nine months. For the full year 2021, Munich Re anticipates that it will still meet its overall profit target of €2.8bn.

This forecast takes into account higher COVID-19-related losses for life and health reinsurance than expected at the time the Q2 results were announced. As already intimated at the time, Munich Re will therefore not reach its technical result target** of €400m for this year. In property-casualty reinsurance, there were no noteworthy COVID-19 losses in Q3.

Munich Re will announce its final Q3 result, as scheduled, on 9 November.


* Average of estimates from 15 financial analysts
** Including the result from insurance contracts with non-significant risk transfer




Contact:
Dr. Stefan Gehring
General Counsel & Group Chief Compliance Officer

19-Oct-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Infineon Technologies AG: Aufsichtsrat beruft Jochen Hanebeck zum Nachfolger von Dr. Reinhard Ploss als Vorstandsvorsitzenden von Infineon

25. November 2021, 17:45

Aktuelle Research-Studie

3U HOLDING AG

Original-Research: 3U HOLDING AG (von GSC Research GmbH): Halten

26. November 2021